Document Detail


The sodium-iodide symporter expression in placental tissue at different gestational age: an immunohistochemical study.
MedLine Citation:
PMID:  16984250     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Iodide (I(-)) is crucial for foetal thyroid function. Foetal iodide results from maternal circulating iodide and from deiodination of iodothyronines within the placenta. The Na(+)/I(-) symporter (NIS) localized in placental cells appears to be involved in iodide exchange. Low NIS expression has been reported in trophoblast cells from the first trimester and pregnancy at term. AIMS: The aim of this study was to examine NIS expression by immunohistochemistry in the major components of human ovular tissue and placenta. MATERIALS AND METHODS: Formalin-fixed and paraffin-embedded specimens of placental tissue from the first trimester and at term were analysed. NIS expression was quantified as percentage of NIS-positive cells/total cells. NIS expression was also evaluated by real-time polymerase chain reaction (RT-PCR) in five first-trimester and five at-term placental specimens. RESULTS: In the first-trimester specimens heterogeneous NIS immunoreactivity was found in cyto-syncytiotrophoblast cells, with a range of NIS-positive cells from 5% to 80% (mean +/- SD 21.85 +/- 23.95), in mesenchymal and endothelial cells from 1% to 40% (14.5 +/- 11.16), in decidual cells from 5% to 40% (10.38 +/- 11.98) and in endometrial glands from 3% to 40% (21.86 +/- 13.93). In specimens from placenta at term, NIS-positive cyto-syncytiotrophoblast cells were between 5% and 40% (mean 17.85 +/- 18.15), mesenchymal and endothelial cells between 1% and 40% (13.67 +/- 12.16), decidual tissue between 5% and 30% (16.43 +/- 9.08), and endometrial glands between 3% and 40% (16.67 +/- 15.27). No significant differences in NIS expression were observed between the first trimester and placenta at term. A similar level of mRNA expression for the NIS gene was obtained by RT-PCR both in ovular material of the first trimester and in placenta at term. CONCLUSIONS: We found NIS to be expressed in various placental and ovular components and its expression to remain constant during pregnancy.
Authors:
C Di Cosmo; G Fanelli; M Tonacchera; E Ferrarini; A Dimida; P Agretti; G De Marco; P Vitti; A Pinchera; G Bevilacqua; A G Naccarato; P Viacava
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical endocrinology     Volume:  65     ISSN:  0300-0664     ISO Abbreviation:  Clin. Endocrinol. (Oxf)     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-09-20     Completed Date:  2007-04-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  England    
Other Details:
Languages:  eng     Pagination:  544-8     Citation Subset:  IM    
Affiliation:
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Decidua / chemistry
Endometrium / chemistry
Endothelial Cells / chemistry
Female
Gene Expression
Gestational Age
Humans
Immunohistochemistry / methods
Mesoderm / chemistry
Placenta / chemistry*
Pregnancy
RNA, Messenger / analysis
Reverse Transcriptase Polymerase Chain Reaction
Symporters / analysis*,  genetics
Thyroid Gland / chemistry
Trophoblasts / chemistry
Chemical
Reg. No./Substance:
0/RNA, Messenger; 0/Symporters; 0/sodium-iodide symporter

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and ...
Next Document:  Monitoring neuropeptide-specific proteases: processing of the proopiomelanocortin peptides adrenocor...